Old Web
English
Sign In
Acemap
>
authorDetail
>
Leila Nabegh
Leila Nabegh
Ain Shams University
Medicine
Hepatitis C
Pathology
Pegylated interferon
Ribavirin
4
Papers
48
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study
2018
BMJ Open Gastroenterology
Sanaa M. Kamal
Khaled K. Aldossari
Dhalia Ghoraba
Sara Mahmoud Abdelhakam
Amgad H Kamal
Mohamad Bedewi
Leila Nabegh
Khaled Bahnasy
Tamer Hafez
Show All
Source
Cite
Save
Citations (8)
Evaluation of serum fibrotic markers; CTGF, IL-17and TGF-β1 versus liver biopsy for detection of hepatic fibrosis in Egyptian patients with chronic hepatitis C
2017
Meta Gene
Samar K. Kassim
Sanaa M. Kamal
Hanan Shehata
M.M. Salib
Manal L. Louka
Maha Sallam
Leila Nabegh
Show All
Source
Cite
Save
Citations (1)
The accuracy and cost‐effectiveness of hepatitis C core antigen assay in the monitoring of anti‐viral therapy in patients with chronic hepatitis C genotype 4
2015
Alimentary Pharmacology & Therapeutics
Sanaa M. Kamal
Samar K. Kassim
E. El Gohary
A. Fouad
Leila Nabegh
Tamer Hafez
Khaled Bahnasy
H. Hassan
D Ghoraba
Show All
Source
Cite
Save
Citations (16)
Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis
2011
Liver International
Sanaa M. Kamal
Amany I Ahmed
Sara Mahmoud
Leila Nabegh
Iman El Gohary
Isi Obadan
Tamer A. Hafez
Dahlia Ghoraba
Ahmed A. Aziz
Mona Metaoei
Show All
Source
Cite
Save
Citations (23)
1